Abstract:
The present invention relates to a transition metal-ligand complex that shows changes in its luminescence lifetime characteristic and/or luminescence intensity as a function of the polarity and/or hydrogen bonding properties of its environment, and a sensor, probe, system and method based on the complex for detecting the presence, amount or concentration of a polar solvent in a medium.
Abstract:
An apparatus for efficiently preparing spherical metal powder for 3D printing includes a housing, a crucible and a powder collection area arranged in the housing, wherein a turnplate arranged in the collection area is an inlaid structure. A material having a poor thermal conductivity is selected as the base of the turnplate, and a metal material having a wetting angle less than 90° with respect to droplets is selected and embedded into the base to serve as an atomization plane of the turnplate. An air hole is disposed in the turnplate. The spherical metal powder for 3D printing combines electromagnetic force breaking capillary jet flow and centrifugal atomization, which breaks through the traditional metal split mode, and makes the molten metal in a fibrous splitting.
Abstract:
Methods, systems, and computer program products for controlling production systems. Methods include monitoring actual performance of a production system that includes a plurality of machines. The actual performance of the production system is compared to a planned level of performance of the production system. One or more short-term production constraints in the production system are identified in response to the actual performance being more than a threshold value away from the planned level of performance. A corrective action for the production system is determined to mitigate one or more of the short-term production constraints. The corrective action is applied to the production system.
Abstract:
A method for determining whether to provide automatic reset instructions to a machine with reset capability with respect to a fault code event, the method comprising, in a database, collecting records comprising the identification of the machine, a fault code associated therewith and the duration of a fault associated with the fault code that the machine experienced within a time period, and performing a statistical analysis on the records to analyze whether executing an automatic reset on the machine with respect to the fault code will probabilistically rectify the fault and to generate resultant data.
Abstract:
A method for managing an application and an application platform, including: installing, by an application platform, a first application upon receiving a request for installing the first application, and sending a summary of the first application to a server; wherein an application list is maintained for each user in the server, and the application list is to store summaries of all of applications installed by each user; and uninstalling, by the application platform, a second application upon receiving a request for uninstalling the second application, and notifying the server to delete a summary of the second application from an application list corresponding to a user sending the request for uninstalling the second application; wherein the first application and the second application are a same application or different applications.
Abstract:
A web site usage pattern insight platform may be provided. User behaviors associated with web page requests, including search queries, may be captured and analyzed to provide usage pattern insights. The pattern insights may be aggregated across a plurality of users and may be used to provide recommendations for improving a system that hosts the web pages.
Abstract:
A costing process that takes advantage of real-time information about plant floor activities and provides a more accurate and timely financial feedback about the process efficiencies in response to new changes in the process operation. The costing process includes identifying stations that consume resources, consume activities and supply activities. The costing process also identifies a plurality of resources that are provided to one or more of the stations. The costing process also includes identifying resources from the plurality of resources that are used as needed and resources that are supplied in advance of being used. The costing process allocates costs for each resource to each station that the resource supplies, including calculating a cost rate, calculating a cost of used capacity and calculating a cost of unused capacity. The costing process then determines the cost that each station and product uses based on the allocations.
Abstract:
A system, method, and apparatus are provided for maintenance opportunity planning in a production line having a plurality of machines and buffers between machines on the production line, with the buffers processing production units between at least two of the machines. The system, method, and apparatus advantageously indicates maximum allowed downtime for a machine, through monitoring the status of the buffers to determine whether the flow of units through the buffers is favorable, monitoring the status of the plurality of machines, and determining which of the plurality of machines may be shut down for a particular period of time while substantially maintaining the favorable flow of units through the buffers. In this way, the inventive system and method saves time and resources by reducing production line downtime and unscheduled overtime.
Abstract:
GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving a-GBV-C NS5A peptide or polypeptide for inhibiting and treating HIV infections.
Abstract:
The invention described herein provides human antibodies produced in non-human animals that specifically bind to Streptococcus pneumoniae capsular polysaccharide (PPS-3). The invention further provides methods for making the antibodies in a non-human animal and for expressing the antibodies in cells including hybridomas and recombinant host cell systems. Kits and pharmaceutical compositions comprising the antibodies are also provided in addition to methods of treating, inhibitng or preventing S. pneumoniae infection or conditions or disorders caused by such infection by administering to a patient the pharmaceutical compositions described herein.